Person: Karimah Es Sabar

Microbion Corp received US$25 million in venture funding

Vancouver and Bozeman MT-based -based Microbion Corp has received US$25-million in venture capital to further develop its lead compound for the treatment of antibiotic-resistant infections. The funding is being provided by the Global Health Sciences Venture Fund, a US$500-million joint venture between Vancouver’s Quark Venture Inc and GF Securities, a Hong Kong-based investment bank. The…

Karimah Es Sabar

Karimah Es Sabar has announced that she will be vacating her positions as president and CEO at the Centre for Drug Research and Development (CDRD) at the end of the month. CDRD vice-chair Gordon McCauley will replace Es Sabar as interim CEO while the organization looks for a permanent replacement. In announcing her departure, she…

Dr Guillaume Coté

Dr Guillaume Coté has been appointed VP technology and innovation for the Aerospace Industry Association of Canada (AIAC). Coté comes to AIAC via the Interchange Canada Program from the department of Innovation, Science and Economic Development where he served as deputy director in the aerospace, marine and defence branch. He holds a PhD in urban…

Dr Pam Valentine

Dr Pam Valentine has been appointed transition CEO of the consolidated Alberta Innovates Corp (see lead article). and chair of the new Institutes Advisory Board of on health innovation at the Canadian Institutes of Health Research. The board will provide all 13 CIHR institutes with advice and help identify opportunities for collaboration.Valentine has held several…

Sean Cunliffe

Sean Cunliffe has been appointed CEO of Sitka Biopharma Inc, a spinoff of CDRD Ventures Inc (see brief on this page). Cunliffe is a pharmaceutical sales and marketing executive with more than 30 years of experience working in big pharma. At Sitka he will work with founding scientists Dr Helen Burt and Dr Don Brooks…

Karimah Es Sabar

Karimah Es Sabar has been selected as a recipient of the Canada’s Most Powerful Women Top 100 Awards for 2013 by the Women’s Executive Network’s . Esabar is president and CEO of the Centre for Drug Research and Development (CDRD), Vancouver and founding chair of the Global Alliance of Leading Drug Discovery and Development Centres.…

Mark Lievonen

Mark Lievonen, president of Sanofi Pasteur Ltd, has been appointed chair of the board of directors for Canada’s Research-Based Pharmaceutical Companies (Rx&D) for 2013-14. Lievonen joined Sanofi Pasteur in 1983 and held a number of senior positions before being named president in 1999. Lievonen holds a BBA in accounting and an MBA from the Schulich…

Sean Cunliffe

Sean Cunliffe has been appointed CEO of Sitka Biopharma Inc, a spinoff of CDRD Ventures Inc (see brief on this page). Cunliffe is a pharmaceutical sales and marketing executive with more than 30 years of experience working in big pharma. At Sitka he will work with founding scientists Dr Helen Burt and Dr Don Brooks…

Karimah Es Sabar

Karimah Es Sabar has been selected as a recipient of the Canada’s Most Powerful Women Top 100 Awards for 2013 by the Women’s Executive Network’s . Esabar is president and CEO of the Centre for Drug Research and Development (CDRD), Vancouver and founding chair of the Global Alliance of Leading Drug Discovery and Development Centres.…

Mark Lievonen

Mark Lievonen, president of Sanofi Pasteur Ltd, has been appointed chair of the board of directors for Canada’s Research-Based Pharmaceutical Companies (Rx&D) for 2013-14. Lievonen joined Sanofi Pasteur in 1983 and held a number of senior positions before being named president in 1999. Lievonen holds a BBA in accounting and an MBA from the Schulich…